Thomas Arthur Barrett, MD | |
24 Macarthur Blvd, Somers Point, NJ 08244-1776 | |
(609) 927-1991 | |
(609) 926-0075 |
Full Name | Thomas Arthur Barrett |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 30 Years |
Location | 24 Macarthur Blvd, Somers Point, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427047646 | NPI | - | NPPES |
8076308 | Medicaid | NJ | |
20036777 | Other | NJ | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 25MA06906400 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Shore Medical Center | Somers point, NJ | Hospital |
Cape Regional Medical Center Inc | Cape may court house, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Shore Orthopaedic University Associates Pa | 1254308604 | 12 |
Orthonj Llc | 6800225178 | 276 |
News Archive
A new rule to restrict legal immigration, published by the Trump administration this month, is sowing confusion and anxiety even among immigrants not directly affected by it, as fear spreads faster than facts, immigration and health policy experts say.
Boston Scientific Corporation today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The panel recommended the expansion include the majority of the studied population of the landmark MADIT-CRT clinical trial, which evaluated the ability of these devices to slow the progression of heart failure in patients with asymptomatic or mild heart failure.
Researchers led by Indian-American scientist, Satchidananda Panda at the Salk Institute for Biological Studies in La Jolla, Calif., said the gene is responsible for starting the body's biological clock from its restful state every morning. They add that this may open avenues in research in insomnia or sleeplessness, aging and chronic illnesses.
Unigene Laboratories, Inc. announced today that Novartis has released information on the first of two studies on oral calcitonin for the treatment of osteoarthritis conducted by its license partner Nordic Bioscience. The recently completed Study 2301, which assesses the safety and efficacy of oral calcitonin in the treatment of knee osteoarthritis, had three co-primary endpoints.
At an International Congress on Obesity, in Sydney, Australia, chairman Professor Paul Zimmet has said that obesity is no longer a problem limited to America and other developed countries but has reached the scale of a global epidemic.
› Verified 2 days ago
Entity Name | Shore Orthopaedic University Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114056900 PECOS PAC ID: 1254308604 Enrollment ID: O20040915000061 |
News Archive
A new rule to restrict legal immigration, published by the Trump administration this month, is sowing confusion and anxiety even among immigrants not directly affected by it, as fear spreads faster than facts, immigration and health policy experts say.
Boston Scientific Corporation today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The panel recommended the expansion include the majority of the studied population of the landmark MADIT-CRT clinical trial, which evaluated the ability of these devices to slow the progression of heart failure in patients with asymptomatic or mild heart failure.
Researchers led by Indian-American scientist, Satchidananda Panda at the Salk Institute for Biological Studies in La Jolla, Calif., said the gene is responsible for starting the body's biological clock from its restful state every morning. They add that this may open avenues in research in insomnia or sleeplessness, aging and chronic illnesses.
Unigene Laboratories, Inc. announced today that Novartis has released information on the first of two studies on oral calcitonin for the treatment of osteoarthritis conducted by its license partner Nordic Bioscience. The recently completed Study 2301, which assesses the safety and efficacy of oral calcitonin in the treatment of knee osteoarthritis, had three co-primary endpoints.
At an International Congress on Obesity, in Sydney, Australia, chairman Professor Paul Zimmet has said that obesity is no longer a problem limited to America and other developed countries but has reached the scale of a global epidemic.
› Verified 2 days ago
Entity Name | Orthonj Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720557432 PECOS PAC ID: 6800225178 Enrollment ID: O20200408000333 |
News Archive
A new rule to restrict legal immigration, published by the Trump administration this month, is sowing confusion and anxiety even among immigrants not directly affected by it, as fear spreads faster than facts, immigration and health policy experts say.
Boston Scientific Corporation today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The panel recommended the expansion include the majority of the studied population of the landmark MADIT-CRT clinical trial, which evaluated the ability of these devices to slow the progression of heart failure in patients with asymptomatic or mild heart failure.
Researchers led by Indian-American scientist, Satchidananda Panda at the Salk Institute for Biological Studies in La Jolla, Calif., said the gene is responsible for starting the body's biological clock from its restful state every morning. They add that this may open avenues in research in insomnia or sleeplessness, aging and chronic illnesses.
Unigene Laboratories, Inc. announced today that Novartis has released information on the first of two studies on oral calcitonin for the treatment of osteoarthritis conducted by its license partner Nordic Bioscience. The recently completed Study 2301, which assesses the safety and efficacy of oral calcitonin in the treatment of knee osteoarthritis, had three co-primary endpoints.
At an International Congress on Obesity, in Sydney, Australia, chairman Professor Paul Zimmet has said that obesity is no longer a problem limited to America and other developed countries but has reached the scale of a global epidemic.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Thomas Arthur Barrett, MD 24 Macarthur Blvd, Somers Point, NJ 08244-1776 Ph: (609) 927-1991 | Thomas Arthur Barrett, MD 24 Macarthur Blvd, Somers Point, NJ 08244-1776 Ph: (609) 927-1991 |
News Archive
A new rule to restrict legal immigration, published by the Trump administration this month, is sowing confusion and anxiety even among immigrants not directly affected by it, as fear spreads faster than facts, immigration and health policy experts say.
Boston Scientific Corporation today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The panel recommended the expansion include the majority of the studied population of the landmark MADIT-CRT clinical trial, which evaluated the ability of these devices to slow the progression of heart failure in patients with asymptomatic or mild heart failure.
Researchers led by Indian-American scientist, Satchidananda Panda at the Salk Institute for Biological Studies in La Jolla, Calif., said the gene is responsible for starting the body's biological clock from its restful state every morning. They add that this may open avenues in research in insomnia or sleeplessness, aging and chronic illnesses.
Unigene Laboratories, Inc. announced today that Novartis has released information on the first of two studies on oral calcitonin for the treatment of osteoarthritis conducted by its license partner Nordic Bioscience. The recently completed Study 2301, which assesses the safety and efficacy of oral calcitonin in the treatment of knee osteoarthritis, had three co-primary endpoints.
At an International Congress on Obesity, in Sydney, Australia, chairman Professor Paul Zimmet has said that obesity is no longer a problem limited to America and other developed countries but has reached the scale of a global epidemic.
› Verified 2 days ago
Dr. Kristen E Radcliff, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 New Rd Ste 3, Somers Point, NJ 08244 Phone: 609-800-3472 Fax: 609-800-3472 | |
David M Anapolle, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 547 New Rd, Somers Point, NJ 08244 Phone: 609-927-9200 Fax: 609-927-1616 | |
Richard Barnard Islinger, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Macarthur Blvd, Somers Point, NJ 08244 Phone: 609-927-1991 Fax: 609-926-0075 | |
Edward John Armbruster, D.O., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Macarthur Blvd, Somers Point, NJ 08244 Phone: 609-927-1991 Fax: 609-926-0075 | |
Dr. Jasmine Bauknight, M.D Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 710 Center St Fl 2, Somers Point, NJ 08244 Phone: 609-365-6280 | |
Mark Austin Pastore, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 24 Macarthur Blvd, Somers Point, NJ 08244 Phone: 609-927-1991 Fax: 609-926-0075 | |
Eugene John Demorat, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Macarthur Blvd, Somers Point, NJ 08244 Phone: 609-927-1991 Fax: 609-926-0075 |